Table 1 Characteristics of axSpA patient cohorts
Cohort 1 | Cohort 2 | |||||
|---|---|---|---|---|---|---|
axSpA (n = 25) | HC (n = 10) | axSpA (n = 32) | HC (n = 22) | |||
nr-axSpA (n = 10) | AS (n = 15) | nr-axSpA (n = 9) | AS (n = 23) | |||
Age [years], mean (± SD) | 34.4 (± 8.8) | 40.4 (± 11.4) | 35.5 (± 9.6) | 49.2 (± 11.8) | 51.4 (± 8.5) | 52.5 (± 11.9) |
Sex [male], n (%) | 5 (50) | 10 (66.7) | 5(50) | 5 (56) | 15 (65) | 2 (9) |
Disease duration [years], mean | 5.7 | 10.6 | - | 26.9 | 30 | - |
BASDAI, mean (± SD) | 3.8 (± 2.2) | 4.2 (± 1.9) | - | 4.6 (± 1.6) | 3.4 (± 2.3) | - |
BASDAI ≥ 4, n (%) | 3 (30) | 9 (60) | - | 6 (67) | 10 (43) | - |
ASDAS-CRP, mean (± SD) | 2.0 (± 0.9) | 2.3 (± 0.8) | - | n.a. | n.a. | - |
CRP [mg/l], mean (± SD) | 0.9 (± 0.9) | 5.1* (± 6.4) | 1.5 (± 1.6) | n.a. | n.a. | - |
Uveitis#, n (%) | 1 (10) | 3 (20) | - | 0 (0) | 9 (39) | - |
Arthritis#, n (%) | 5 (50) | 1 (7) | - | 6 (67) | 14 (61) | - |
Enthesitis#, n (%) | 4 (40) | 4 (27) | - | 9 (100) | 15 (65) | - |
Psoriasis#, n (%) | 4 (40) | 3 (20) | - | 1 (11) | 3 (13) | - |
IBD#, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | - | |